[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340809-105":59,"doc-detail-340809-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","investigation-of-5-fluorouracil-cardiotoxicity-in-combinational-therapy-influence-of-risk-factors-and-demographics-in-a-pakistani-population","Investigation of 5-Fluorouracil Cardiotoxicity in Combinational Therapy - Influence of Risk Factors and Demographics in a Pakistani Population","","5-Fluorouracil (5-FU) is widely used for cancer therapy but is consistently linked to cardiotoxicity. This prospective study evaluated cardiotoxicity parameters and predictors across GI/colorectal cancer patients receiving different 5-FU-based chemotherapy protocols, focusing on age, sex, cumulative dose, and risk factors including obesity, hypertension, and family cardiac history. ECG and serum troponin assessed events; treatment interruption and cardiac monitoring followed detection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigation-of-5-fluorouracil-cardiotoxicity-in-combinational-therapy-influence-of-risk-factors-and-demographics-in-a-pakistani-population/340809/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigation-of-5-fluorouracil-cardiotoxicity-in-combinational-therapy-influence-of-risk-factors-and-demographics-in-a-pakistani-population/340809.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the study?","Question",{"text":112,"@type":113},"To assess cardiotoxicity parameters and predictors associated with different 5-FU-based chemotherapy protocols, and to examine correlations with age, sex, cumulative dose, and risk factors such as obesity, hypertension, and family history.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was 5-FU-induced cardiotoxicity evaluated?",{"text":117,"@type":113},"Patients underwent electrocardiography and serum troponin testing. Cardiotoxicity detection triggered interruption of 5-FU and initiation of nitroglycerin/nitrates/calcium channel blockers and cardiac monitoring.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were linked to developing cardiotoxicity?",{"text":121,"@type":113},"Pre-existing cardiac diseases, treatment duration, smoking, and obesity were identified as influential components. Patients receiving combination therapy showed cardiotoxic events significantly different from monotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340809,1790653932,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Original Article  \nInvestigation of 5-ﬂuorouracil  \ncardiotoxicity in combinational therapy: Inﬂuence of risk factors and demographics in a Pakistani population  \nHina Raza 1, Mariyam Javaid 1, Wajiha Rehman2, Sana Raﬁq3, Zermina Rashid4, Rahat Shamim5, Abdolelah Jaradat6 and Mohamed Deifallah Yousif7   \nJ Oncol Pharm Practice 2025, Vol. 31(7) 1037–1045 © The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10781552241275948](DOI: 10.1177/10781552241275948)[ ](DOI: 10.1177/10781552241275948)[journals.sagepub.com/home/opp](journals.sagepub.com/home/opp)  \nAbstract  \nIntroduction: 5-Fluorouracil (5-FU) is a chemotherapeutic agent used to treat various types of cancers. Although widely used, it has consistently been attributed to cardiotoxicities after administration. The purpose of this study was to assess the parameters and predictors of cardiotoxicities associated with various 5-FU-based chemotherapeutic protocols inpatients with GI/colorectal cancer, as well as the correlation of these cardiotoxic events with age, sex, cumulative dose, and risk factors such as obesity, hypertension, and family history of cardiac diseases.  \nMethods: A prospective study consisting of 396 patients of both sexes was conducted in the oncology ward of Nishtar Hospital in Multan, Pakistan. Patients were grouped according to the therapeutic protocol they received (5-FU monotherapy or in combination, with different dosing regimens). Electrocardiography and serum troponin levels were used to assess 5-FU-induced cardiotoxicity. In cases where cardiotoxicity was detected, 5-FU treatment was interrupted; nitroglycerin, nitrates, and calcium channel blockers were administered; and cardiac monitoring was initiated. 5-FU was discontinued in all cases of acute myocardial infarction.  \nResults: Of the 396 patients, 28.5% reported different cardiotoxic symptoms after receiving various 5-FUcontaining protocols. 35% had anginal pain, 13% suffered a myocardial infarction, 11% developed hypertension, and 10% presented heart failure. Patients receiving 5-FU combination therapy showed cardiotoxic events that were signiﬁcantly different from those on 5-FU monotherapy. Based on the ECG results, only the QTc-d interval increased signiﬁcantly (p\u003C0.001) after therapy. 68% of the patients had troponin levels >2 ng/mL at the end of treatment.  \nConclusions: Pre-existing cardiac diseases, treatment duration, smoking, and obesity were found to be inﬂuential components in the development of cardiotoxicity, and patients with cancer should be closely monitored during 5-FU chemotherapy.  \nKeywords  \nCardiotoxicity, 5-Fluorouracil, cancer chemotherapy, combinational therapy, risk factors  \nDate received: 11 March 2024; revised: 31 July 2024; accepted: 2 August 2024  \nIntroduction  \nA high proportion of cardiac events has been reported inpatients receiving chemotherapy in the past few years.1 Cardiac abnormalities that develop in response to chemotherapy need more attention in comparison with the usual cardiac events caused by drug toxicity due to overdose, for instance, as they could be spontaneous and occur suddenly. Therefore, the cardio-oncology ﬁeld has recently emerged, which is anew discipline that provides knowledge and information for early screening and clinical monitoring of cardiovascular changes during cancer treatment to reduce oncological comorbidities and mortality.2  \n1 Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan 2Department of Health Informatics, Jazan University, Jazan, Saudi Arabia 3King Edward Medical University, Mayo Hospital Lahore, Lahore, Pakistan 4Department of Pharmacy, The Women University Multan, Multan, Pakistan  \n5Punjab University College of Pharmacy, University of the Punjab, Punjab, Pakistan  \n6Faculty of Pharmacy, Isra University, Amman, Jordan  \n7UCL School of Pharmacy, University College London, London, UK  \n","cbCaieArDZh69MVm","https://ap.wps.com/l/cbCaieArDZh69MVm","pdf",818207,"English","# Abstract\n# Introduction\n## Rationale and background\n## Prior evidence on 5-FU cardiotoxicity\n# Methods\n## Study design and participants\n## Assessment and clinical management\n# Results\n## Symptom and diagnosis distribution\n## ECG and troponin findings\n# Conclusions","[{\"question\":\"What was the main purpose of the study?\",\"answer\":\"To assess cardiotoxicity parameters and predictors associated with different 5-FU-based chemotherapy protocols, and to examine correlations with age, sex, cumulative dose, and risk factors such as obesity, hypertension, and family history.\"},{\"question\":\"How was 5-FU-induced cardiotoxicity evaluated?\",\"answer\":\"Patients underwent electrocardiography and serum troponin testing. Cardiotoxicity detection triggered interruption of 5-FU and initiation of nitroglycerin/nitrates/calcium channel blockers and cardiac monitoring.\"},{\"question\":\"Which factors were linked to developing cardiotoxicity?\",\"answer\":\"Pre-existing cardiac diseases, treatment duration, smoking, and obesity were identified as influential components. Patients receiving combination therapy showed cardiotoxic events significantly different from monotherapy.\"}]","Investigation of 5-Fluorouracil Cardiotoxicity in Combinational Therapy - Influence of Risk Factors and Demographics in a Pakistani Population | PDF",1790038962,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea33783365e3d12a4a41b87c23dbdae3.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2c72987bacd3eef4d8c8d0ddec04c41.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40d3ff2627f7a7009404aa5ad42994d4.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f1c15225000e37747527845b3af7020.webp",980,1306]